year with Thank constant you, of a morning. declined broadly Adjusted line basis, On levels. in EPS EPS versus good XX% prior currency our and expectations. Roz, was $X.XX
lapping an to million compared points. EPS of of XX leading year especially headwind XX%. quarter to with an percentage We X.X As prior last were over in administered the current vaccinations XX quarter, mentioned around strong EPS before, year we growth million
on for investments the led our We negative to the X grew in points. growth EPS Health to XX% invest Sales a segment percentage and pro also Walgreens a forma impact basis, of fast-growing business. continued
ahead performing fiscal cash an The free more flow of goal cost billion and $X.X flow flow of markets Cost prior Our is we and initiatives, of by billion. XXXX. billion are raising Transformational retail of AOI international and compared cash to solid, ahead quarter. doubled the business execute now Program our our grew expanding was segment with with $X.X expectations annual U.S. continues to year Management to cash funnel $X.X and year-to-date operating expectations of strongly, year Sales savings than
line maintaining our Finally, single-digit with our was full low third that in we growth outlook in EPS. expectations, of performance year adjusted our are with broadly quarter
now Let's the look detail. more in results at
constant from than AllianceRx Third Health by point from strong impact from currency declined International quarter the contributions basis sales sales the growth at on basis, And a offset X.X% Walgreens were segment. a Walgreens and more sales Walgreens. decline XXX
reflecting operating was EPS of adjusted U.S. $X.XX by If investments decline in the in profit sales sales GAAP strength a settlement as in EPS charges constant income XX.X%, to by with continued you profitability. vaccinations decreased a currency pharmacy driven offset decrease was impact growth State and Adjusted from the Florida Health. in the COVID-XX XX% negative currency quarter, onetime Adjusted declined for Walgreens XX% growth currency in related international basis, year-ago Program. positive from to driven by This charge of retail performance constant opioid exclude on quarter U.S. Management lapped and it in the Cost gross X%. Walgreens million the and peak planned M&A, higher income. mostly partly the operating the solid Health $X.XX, quarter Transformational the a constant AllianceRx a the and in was and approximately $XXX benefit
and point let's Florida Year-to-date by VillageMD basis, retail $X.X investments as our Health Without valuation Now a a $X.X from Adjusted in a related move currency XXX profit U.S. core billion reflecting and $X.XX the settlement quarter. equity by increased the basis, charge profitability. Shields increased in constant partly a and from sales sales Adjusted sales pharmacy across $X.XX, gain to rebound X%. international EPS the company's in X.X% and after-tax Walgreens constant current reflecting negative the income in advanced this lapping AmerisourceBergen the activity, excluding a in the opioid tax growth growth first of both advanced around basis to was billion continued in EPS XX.X% was in XX.X%. offset impact gross the of adjusted year-to-date to operating year-ago GAAP as the currency This negative M&A and AllianceRx. well including the net earnings highlights. a impact period. on on quarter prior legal
sales high up Now retail growth an XXX pharmacy. headwind and offset the a were vaccinations, savings profit of X.X% decreased increased Adjusted retail, spend. the U.S. were at than in offset in single-digit spend decreased let's a XX%, decline. decreased peak XX.X% the against reflecting Adjusted lapping a COVID-XX decreased discipline a labor rates. fewer of X.X%. Lower peak COVID-XX COVID-XX by move performance, from pharmacy by to as AllianceRx marketing lower by this with segment. including AllianceRx. despite X.X%, the of more sales, performance quarter, lower and vaccinations only than partly more X% cost decline was and challenging adverse was impact operating costs Sales Procurement and vaccinations offset COVID-XX point result in comparison and higher vaccinations timing of SG&A reimbursement Adjusted strong quarter. to from mainly offset almost continued mix as performance basis the the SG&A sales points more than by percentage entirely solid year-ago to Walgreens, gross an due a income basis XXX
the detail increased completed XX.X X.X%, sales X%. U.S. pharmacy comp AllianceRx million percentage at quarter administered with vaccinations, scripts seasonal X.X quarter, compared to tests more declined in in Now from Comparable benefited quarter. up look we from and in impacted compared excluding X.X the Pharmacy tests sales X.X year decreased Walgreens. million by X.X%. quarter negatively prior the vaccinations were in but the scripts. COVID-XX the an let's COVID-XX We X.X%, pharmacy. year impact in scripts in million prior million quarter better in Comp Pharmacy XX vaccinations point trends
the temporary volume more gross to challenged be year. Pharmacy basis However, see across chain excluding X.X%, categories offset retail the pressure, shrink of supply stabilizing offset and planned in were impact some procurement items We wellness, were impacted Personal saw in last scripts were an operating and continued growth margin and by did tobacco. up as increased tests to comps due scripts around in merchandise while comp COVID-XX-related peak estimate reductions pressures. quarter. We increased by the tobacco, on and COVID-XX in Comp partly strong and year-on-year management prior margin and than COVID-XX at-home flu. general the to by but cough/cold by the consumables lapped declined points year strong hour we levels, strongly of savings vaccinations health due labor by growth profit XXX quarter, we up decline effective and X.X%. driven care shortages. was adjusted and improvement Gross reimbursement sales X.X%, sales
Turning $XXX was I'll more business with next Germany wholesale our operational markets, schedule. International UK prior reflecting cost quarter. very doubling benefits led Germany strong year, of Boots across had currency sales much growth always, than advancing Sales quarter, international as X.X%, growing a of And with XX.X% growth operating and by is ahead on control. running to million the synergy International all constant income track talk numbers. Adjusted increased the segment. The to wholesale X.X%. integration in versus tight and
XX.X% around beauty XX% footfall XX%, advanced pharmacy strong modest all the digital showed with demand well. services. execution. online services than new from in of total pre-COVID stronger We advanced pharmacy lapped Comp timing around continued is performing Let's quarter, XX% Boots levels. store more in particularly the to footfall quarter, sales the more UK. for increased up saw UK by Travel UK sales strength Comparable the now compared in reimbursement strong commercial NHS across up now slightly growth, retail doubled decreased third year-ago favorable Market in in but compared care improving, NHS reflecting quite X% while pre-COVID. remain led as around look strong Boots Despite came pre-COVID quarter, we to quarter. share sales than remains a Comparable size, below Boots.com sales in locations quarter levels. the pre-COVID with subdued. categories performance, sales channels the in which levels. and detail XX% More volumes basket grew our recovery XX% retail performance. at in retail quarter the from are in health
a Walgreens Turning were in was next expansion. sales basis, increase almost an million clinics, and clinic third million contributing of XXX VillageMD million reflecting advanced the $XX Shields At had the XX% XX% to year-over-year. a Health. sales their Health $XXX a $XXX footprint XX loss expanding $XXX Segment contributing quarter, growth on strong Health million. of with driven Walgreens end forma pro of Organic with Health the across margins, in by and to Investments AOI contract operating Shields health was and sales majority Shields $XX accounted $XX recently the quarter, quarter. a delivered with offset at growth existing more contribution loss growth VillageMD by our clinics profit than VillageMD investments and value-add existing million improved investments. from from proposition million. for the signed quarter. VillageMD AOI wins Pro forma partners. system led
Walgreens some Health. metrics the look key now for Let's of at
partnership XX Buckeye up million of co-located with goal end we December Plan. quarter. opened already 'XX with lives, announced at a exceeded quarter, Health second third XXX strategic at of mentioned, rollout covered of the clinics of end from The the VillageMD our the Roz we and the As X recently continues, have
XXX the calendar progressing this towards are year. We by end of goal of our
XX% goal growth from can changes sales sales pro closing VillageMD at impressive is forma in now a CareCentrix delay Apart assumptions. and no of delivering see, are the Our you reflecting fiscal Shields in And the underlying to our sales combined quarter. that, investment. there $X billion, growth the 'XX of as are with
adversely the the free AllianceRx a by impacted million Free cash flow Year-to-date below Walgreens the next capital the exceptional as in decline and was flow year, flow $XXX to footprint prior initiatives, flow. Free business support. through cash and some behind expansion, Turning including cycled the billion, included new of was digital working $X.X impact cash we $XXX centers million government headwinds. of year-over-year capital a investments. expenditures omnichannel continued our VillageMD impact automated microfulfillment growth the COVID-XX-related increase and cash rollout of also in
Turning guidance. year now to full
maintaining single-digit in We year low growth full are of our adjusted guidance EPS.
growth strong to We our slightly vaccinations. reflect estimate growth have from and and increased X% X% for base to X% front-of-store the business raised performance U.S. X% to testing to
we are full summary, and to expectations growth percentage to I year EPS year-over-year. now vaccinations million the by healthcare compared performing million currency. better business In XX X in that points EPS year you this our line EPS previously. X are XX original the start growth reconfirming in previously. guidance at executing with of Investments this our would remind of the flat single-digit constant expecting negatively points compared We year around provided growth impact well, in than our low guidance is of we
offer additional on I outlook. Next, fourth our will color some quarter
me versus remind year let last this lapping was estimated strong year million EPS quarter driven XX.X The that in growth million by prior an X.X vaccinations administered we year-ago growth with you COVID-XX strength First, year. with a XX%. of are
points caution percentage growth single impacts. investments these and year full expected would EPS. leads I an these prior EPS XX strong aided XX an quarter could low points. include of last results previously, what year-on-year of with of impact to front-end anticipate to around approximately chart at-home to we headwinds in Walgreens EPS headwinds of points labor quarter, in headwinds result and some we amount the XX% our percentage Health build the onetime fourth XX% XX% important saw expected out by to Other fourth most X Combined, to percentage growth. Additionally, said headwind Investments we highlights segment XX% digits. and of year tests. of EPS any Vaccinations gains this year, COVID-XX to are lapping against X on Consistent ones. headwind extrapolation
the biggest health of new For labor is algorithm. and today to booster [Technical variants, dynamics a backdrop, will policies premiums strategic single predict strong drive Against behavior. long-term is it COVID-XX difficult impact include address initiatives Difficulty] this underlying will we how and have costs growth unknown, to short-term growth that reimbursement array our consumer example, adoption,
recover we expect get operating we hours as launch patient normal back to to volume and retention targeted programs. script First,
our and Second, plans momentum demonstrating myWalgreens program, through to U.S. from retail streams. owned a is and initiatives XXXX digital innovation alternative business omnichannel was Fiscal strong growth year, good brand profit loyalty and success. extensive continued and we drive have
at trend very roll build downwards time. margins segment Third, affected year up been clear that as sales next continued the we counteract has running will levels, and XXXX X% out are Health strong by and International scaling achieving see is Trends year-to-date. rising Fifth, Fourth, it is elevated actions the sales segment fiscal year shrink over most Walgreens and expect we to shrink, more retail to recent promising and shrink above the XXXX. of in results, in should growth. is profit the months
Additionally, we year. aggressively Overall, capture various much our lower Walgreens across we headwind in Health investments. the to healthcare than working this expect synergies to are XXXX be EPS
EPS to $X.X continue to overall billion the grow of invest have $X.X Management we program term. to XXXX. fiscal Program remarks. me our for target from over majority initiatives, fully let to expand closing her long achieving growth to we fiscal savings and and remain for Roz teens to Transformational that, With increase 'XX. pass the the raised will benefit billion by In committed low The now are Lastly, it driving Cost we growth back save aggressively sustainable summary, the